According to Lyell Immunopharma's latest financial reports the company has $0.65 B in net assets.
A companyโs net assets is the sum of its assets minus the sum of its liabilities.
Year | Net assets | Change |
---|---|---|
2023-12-31 | $0.65 B | -21.4% |
2022-12-31 | $0.83 B | -10.38% |
2021-12-31 | $0.92 B | 29.42% |
2020-12-31 | $0.71 B | 76.06% |
2019-12-31 | $0.40 B |